Literature DB >> 3718795

A new method for evaluating the effect of antiarrhythmic drugs on atrioventricular nodal conduction.

S Lévy, J Hilaire, H Albin, J L Corbelli, J P Burtey, H Bricaud, R Gérard.   

Abstract

Electrophysiological variables were studied in 19 patients before and after one of three commonly used antiarrhythmic agents. The pacing rate at which alternating Wenckebach periods appeared in eight patients was significantly reduced by intravenous digoxin (0.01 mg/kg body weight). The atrioventricular nodal conduction time (A-H interval) and Wenckebach point were not significantly altered by digoxin. Intravenous propranolol (0.1 mg/kg body weight) in four patients did not affect the A-H interval, but it reduced the pacing rates at which the Wenckebach point and alternating Wenckebach periods occurred. Intravenous disopyramide (2 mg/kg body weight) significantly increased the pacing rate required to produce alternating Wenckebach periods but did not significantly alter the other indicators of atrioventricular conduction in seven patients. It is concluded that the pacing rate required to produce alternating Wenckebach periodicity may be a useful and sensitive variable in the evaluation of the effect of antiarrhythmic agents on atrioventricular nodal conduction.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3718795      PMCID: PMC1236763          DOI: 10.1136/hrt.55.6.569

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  21 in total

1.  Electrophysiological evaluation of disopyramide in man.

Authors:  M E Josephson; A R Caracta; S H Lau; J J Gallagher; A N Damato
Journal:  Am Heart J       Date:  1973-12       Impact factor: 4.749

2.  Conduction disturbances located within the His bundle.

Authors:  R M Schuilenburg; D Durrer
Journal:  Circulation       Date:  1972-03       Impact factor: 29.690

3.  The clinical use of serum cardiac glycoside concentration measurements.

Authors:  T W Smith
Journal:  Am Heart J       Date:  1971-12       Impact factor: 4.749

4.  Catheter technique for recording His bundle activity in man.

Authors:  B J Scherlag; S H Lau; R H Helfant; W D Berkowitz; E Stein; A N Damato
Journal:  Circulation       Date:  1969-01       Impact factor: 29.690

5.  [Second degre Wenckebach phenomenon. Electrocardiographic and clinical study apropos of 10 cases].

Authors:  C Guérot; P E Valère; A Castillo-Fenoy
Journal:  Arch Mal Coeur Vaiss       Date:  1975-11

6.  Alternate ventriculoatrial Wenckebach conduction.

Authors:  S Levy; R Roudaut; E Bouvier; I W Obel; J Clementy; H Bricaud
Journal:  Circulation       Date:  1980-03       Impact factor: 29.690

7.  Pacing-induced alternate Wenckebach periods: incidence and clinical significance.

Authors:  S Lévy; B Pouget; J Clementy; M Bemurat; H Bricaud
Journal:  Pacing Clin Electrophysiol       Date:  1979-11       Impact factor: 1.976

Review 8.  Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-05       Impact factor: 9.546

9.  The relationship between posture, blood pressure and electrophysiological properties in patients with paroxysmal supraventricular tachycardia.

Authors:  P V Curry; E Rowland; K M Fox; D M Krikler
Journal:  Arch Mal Coeur Vaiss       Date:  1978-03

10.  Multilevel block in the atrioventricular node during atrial tachycardia and flutter alternating with Wenckebach phenomenon.

Authors:  R Slama; J F Leclercq; M Rosengarten; P Coumel; Y Bouvrain
Journal:  Br Heart J       Date:  1979-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.